AI Won’t Replace Clinical Trial Teams, But It Fixes the Bottlenecks That Keep Patients Out
We don’t have a shortage of willing patients — instead we have a shortage of scalable ways to identify and engage them responsibly. AI, used meaningfully offers a reliable path forward.
Why Pure DTC Doesn’t Work in Healthcare, Per Muse Capital
Rachel Springate, general partner at Muse Capital, said the next wave of healthcare startups will be driven by consumer demand — but pure direct-to-consumer models rarely work. Companies like Midi Health, Mavida Health and Mahmee are showing a different path: starting with patients, collecting outcomes data, and integrating with clinicians, payers and the broader healthcare system.
12 Senate Democrats Unveil Plan to Cut Costs, Expand Coverage
In a recent letter, Senate Democrats proposed lowering healthcare costs, expanding coverage and cracking down on insurance company practices.
Why Novartis Is Paying $2B for a Cancer Drug That Hits the Same Target as One of Its Own Products
Novartis already markets the PI3Kα inhibitor Piqray for breast cancer, but acquiring a Synnovation Therapeutics subsidiary brings an early clinical program that the pharma company claims could be best in the class of next-generation therapies for the target. Competitors include Eli Lilly, Relay Therapeutics, and OnKure Therapeutics.
Imaging Interoperability Offers a Lifeline to Rural Hospitals and the Patients Depending on Them
Typically, rural hospitals operate as “islands,” where a patient might receive an initial scan at a community health facility, see a specialist at a regional medical center, and return home for follow-up care. In this scenario, it’s common for their medical images to become trapped in three different systems.